Showing results (921-930 of 6,261) with videos related to
Sort By:
Pageof 627
Leukemia Research|January 1, 1990
Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesisC M Bunce, W N Patton, J D Pound, et al.Journal of Leukocyte Biology|August 1, 2002
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokinesGraham M Lord, Giuseppe Matarese, Jane K Howard, et al.Alimentary Pharmacology & Therapeutics|September 11, 2019
Review article: impact of exercise on physical frailty in patients with chronic liver diseaseFelicity R Williams, Annalisa Berzigotti, Janet M Lord, et al.Cancer Research|January 15, 1996
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumorsS M Evans, W T Jenkins, B Joiner, et al.The American Journal of Pathology|January 27, 2004
Leptin-deficient mice are protected from accelerated nephrotoxic nephritisRuth M Tarzi, H Terence Cook, Ian Jackson, et al.Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.Hematology (Amsterdam, Netherlands)|June 15, 2007
Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complexElisabeth Ersvaer, Peter Hampson, Øystein Wendelbo, et al.Psychiatric Services (Washington, D.C.)|July 27, 2022
Peer Support Specialist Work and Experiences During the COVID-19 Pandemic: A National Longitudinal StudyWallis E Adams, E Sally Rogers, Emily M Lord, et al.Transplantation|January 15, 1997
Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcomeA D Salama, T Rogers, G M Lord, et al.FEBS Letters|May 5, 1997
Restoration of lectin activity to a non-glycosylated ricin B chain mutant by the introduction of a novel N-glycosylation siteJ Zhan, M de Sousa, J A Chaddock, et al.Pageof 627